Interacting Drugs |
Efavirenz, emtricitabine, and tenofovir vs Bepridil [Off Market] |
Security Level |
 |
Mechanism |
Bepridil [Off Market]: Efavirenz may enhance the arrhythmogenic effect of Bepridil [Off Market]. |
Management |
Avoid combination |
Efavirenz, emtricitabine, and tenofovir vs Bepridil [Off Market]
Post Review about Efavirenz, emtricitabine, and tenofovir vs Bepridil [Off Market] Click here to cancel reply.
Other Interactions of Efavirenz, emtricitabine, and tenofovir
Other Interactions of Bepridil [Off Market]
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.